Author

Remco Visser

SanquinORCID 0000-0002-5846-7223Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 3 Organism:mouse· 3 Research Focus:differential expression· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Gestur VidarssoniD· 5 shared Anja LuxiD· 3 shared Ann‐Kathrin Schneider· 3 shared Colin Osterloh· 3 shared Frank PeterseniD· 3 shared Katja BieberiD· 3 shared Mareile SchlotfeldtiD· 3 shared Nancy ErnstiD· 3 shared

Activity by Year

2025-2026 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersImmunology

Gestur VidarssonORCID

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

An unbiased map of FcγR signaling in neutrophils reveals druggable nodes in immune complex-mediated autoimmune disease

Mareile Schlotfeldt, Colin Osterloh, Anika Kasprick, Carla Zünkeler, Mikko Armbrust, Georg Kaiser, Katharina Schulze Dieckhoff, Thorge Mester, Pia Stüssel, Nancy Ernst, Ann‐Kathrin Schneider, Leonie Voss, Adrian Pablo Mansini, Seyed Mohammad Vahabi, Yulu F. Wang, , Katja Bieber

The paper identifies BTK as a therapeutic target in antibody-mediated autoimmune diseases by mapping FcγR signaling in neutrophils using kinase inhibitors and disease models.

bioRxiv · Oct 19, 2026 · PreprintImmunology

Disentangling maternal pregnancy and fetal-specific plasma signatures through integrated proteomics and site-specific N-glycoproteomics

Shelley Jager, Sofia Kalaidopoulou Nteak, Grigory Reznikov, Francine R. Ianiski, Remco Visser, Pavel G. Sinitcyn, Gestur Vidarsson, Albert J. R. Heck

The paper identifies pregnancy-specific and fetal-specific plasma proteomic and N-glycoproteomic signatures by comparing maternal, cord blood, and non-pregnant control samples.

bioRxiv · Oct 6, 2026 · PreprintDevelopmental Biology

CDK7, CDK9, or CDK11 Inhibition Reduces Neutrophil-Driven Inflammation and Tissue Damage in Experimental Autoimmune Models

Mareile Schlotfeldt, Leonie Voss, Adrian Pablo Mansini, Daniel Mehlberg, Sophia Johannisson, Michael Radziewitz, Ann‐Kathrin Schneider, Seyed Mohammad Vahabi, Yulu Wang, Haley Gainer, Jing Li, Colin Osterloh, Nancy Ernst, Remco Visser, Gestur Vidarsson, , Katja Bieber

Cell Communication and Signaling · Sep 30, 2026Peer-reviewedImmunology

Patient-derived monoclonal anti-HPA-1a can induce platelet activation through FcγRIIa

Janita J. Oosterhoff, Suze Rosanne van Brummelen, Marco Giulini, Iris M. De Cuyper, Remco Visser, Rick Kapur, Christoph Gstöttner, Elena Domínguez‐Vega, Thijs W. de Vos, Suzanne Hofstede‐van Egmond, Mark Steven Cragg, Manfred Wuhrer, Leendert Porcelijn, Masja de Haas, Alexandre M. J. J. Bonvin, , Gestur Vidarsson

The paper characterizes two anti-HPA-1a antibodies from a severe FNAIT case, showing functional differences in platelet activation through FcγRIIa engagement.

bioRxiv · Sep 17, 2026 · PreprintImmunology

ERK5 is required for neutrophil-mediated ROS release and essential in epidermolysis bullosa acquisita

Sören Dräger, Mareile Schlotfeldt, Leonie Caroline Voß, Sophia Johannisson, Michael Radziewitz, Colin Osterloh, Natalie Gross, Mayumi Kamaguchi, Ann‐Kathrin Schneider, Gestur Vidarsson, Remco Visser, Frank Petersen, Xinhua Yu, Andreas Recke, Nancy Ernst, , Katja Bieber

This study shows ERK5 inhibition reduces neutrophil ROS release and ameliorates EBA, suggesting ERK5 as a therapeutic target in ROS-driven autoimmune diseases.

bioRxiv · Nov 12, 2025 · PreprintImmunology